GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000168310.6 | interferon regulatory factor 2 | |
ENSG00000170581.9 | signal transducer and activator of transcription 2 | |
ENSG00000140968.6 | interferon regulatory factor 8 | |
ENSG00000125347.9 | interferon regulatory factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF1 | hg19_v2_chr5_-_131826457_131826514 | 0.77 | 3.1e-44 | Click! |
IRF2 | hg19_v2_chr4_-_185395672_185395734 | 0.72 | 1.2e-36 | Click! |
IRF8 | hg19_v2_chr16_+_85942594_85942635 | 0.56 | 1.6e-19 | Click! |
STAT2 | hg19_v2_chr12_-_56753858_56753930 | 0.02 | 8.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 1007.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
5.9 | 293.4 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
21.6 | 280.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
34.3 | 274.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
44.8 | 223.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
19.9 | 219.3 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
15.2 | 152.2 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.3 | 140.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
42.8 | 128.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
15.2 | 121.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
69.7 | 557.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 338.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 232.7 | GO:0010008 | endosome membrane(GO:0010008) |
2.8 | 205.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
2.9 | 202.5 | GO:0015030 | Cajal body(GO:0015030) |
30.6 | 183.7 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 179.4 | GO:0031965 | nuclear membrane(GO:0031965) |
9.6 | 173.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 172.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.3 | 162.6 | GO:0005643 | nuclear pore(GO:0005643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.4 | 703.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
9.9 | 308.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.8 | 296.0 | GO:0001047 | core promoter binding(GO:0001047) |
2.4 | 266.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
38.2 | 228.9 | GO:0046979 | TAP2 binding(GO:0046979) |
0.6 | 190.8 | GO:0003924 | GTPase activity(GO:0003924) |
13.8 | 165.3 | GO:0031386 | protein tag(GO:0031386) |
20.9 | 146.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
42.8 | 128.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
11.1 | 121.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 270.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
2.5 | 193.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
6.0 | 179.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.8 | 116.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 103.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
6.7 | 94.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
3.4 | 92.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.2 | 79.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.4 | 76.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.9 | 68.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 855.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
10.1 | 808.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
5.2 | 244.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
6.6 | 235.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
17.8 | 231.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
7.0 | 203.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
17.0 | 170.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
7.6 | 143.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 114.5 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.8 | 83.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |